Drug manufacturer AstraZeneca has submitted its application for emergency use authorization (EUA) of its Covid-19 vaccine, the Food and Drug Administration (FDA) said on Wednesday.

FDA Chief Eric Domingo told multiple media outfits on Wednesday afternoon that Astrazeneca “filed the application just now.”

AstraZeneca will join the Pfizer-BioNTech vaccine as the only two vaccines to have applied for EUA in the country.

According to Domingo, processing and evaluation of EUAs take three to four weeks, “depending on the completeness of their submission.”

Also on Wednesday, the FDA chief said Pfizer’s EUA request might be released on Jan. 14.

AstraZeneca has been approved for emergency use by the UK and India.

Unlike the Pfizer vaccines, AstraZeneca’s do not require cold storage in subzero temperatures.

On Nov. 27, 2020, the Philippines purchased 2.6 million doses of the AstraZeneca vaccines via a tripartite agreement with the private sector for delivery in June 2021. John Ezekiel J. Hirro